Impact of IL2 and IL2RB genetic polymorphisms in kidney transplantation

Transplantation Proceedings

Volumn 43, Issue 6, 2011, Pages 2383-2387

  Park, S J ^a   Yoon, Y C ^a   Kang, S W ^a   Kim, T H ^a   Kim, Y W ^a   Joo, H ^a   Kim, H J ^b   Jeong, K H ^c   Lee, D Y ^c   Lee, S S ^a   Chung, J H ^c   Kim, Y H ^a  

^a Inje University   (South Korea)

^b Soonchunhyang University   (South Korea)

^c Kyung Hee University Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR BETA;

ADULT; ARTICLE; CONTROLLED STUDY; EXON; FEMALE; GENE; GENE FREQUENCY; GENETIC LINKAGE; GENETIC VARIABILITY; GENOTYPE; GRAFT RECIPIENT; HAPLOTYPE; HUMAN; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; KOREA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

ACUTE DISEASE; ADULT; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; EXONS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GRAFT REJECTION; HAPLOTYPES; HUMANS; INTERLEUKIN-2; INTERLEUKIN-2 RECEPTOR BETA SUBUNIT; KIDNEY TRANSPLANTATION; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; REPUBLIC OF KOREA; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME;

EID: 80051701892     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2011.06.014     Document Type: Article

References (34)

1. G.J. Alangaden, R. Thyagarajan, and S.A. Gruber Infectious complications after kidney transplantation: current epidemiology and associated risk factors Clin Transplant 20 2006 401
2. C.M. Vajdic, S.P. McDonald, and M.R. McCredie Cancer incidence before and after kidney transplantation JAMA 296 2006 2823
3. K.A. Bodziak, and D.E. Hricik New-onset diabetes mellitus after solid organ transplantation Transpl Int 22 2009 519
4. S. Badiou, J.P. Cristol, and G. Mourad Dyslipidemia following kidney transplantation: diagnosis and treatment Curr Diab Rep 9 2009 305
5. H. Ekberg Calcineurin inhibitor sparing in renal transplantation Transplantation 86 2008 761
6. O. Wu, A.R. Levy, and A. Briggs Acute rejection and chronic nephropathy: a systematic review of the literature Transplantation 87 2009 1330
7. S.E. Marshall, A.J. McLaren, and N.A. Haldar The impact of recipient cytokine genotype on acute rejection after renal transplantation Transplantation 70 2000 1485
8. S.W. Kang, S.J. Park, and Y.W. Kim Association of MCP-1 and CCR2 polymorphisms with the risk of late acute rejection after renal transplantation in Korean patients Int J Immunogenet 35 2008 25
9. E. Slavcheva, E. Albanis, and Q. Jiao Cytotoxic T-lymphocyte antigen 4 gene polymorphisms and susceptibility to acute allograft rejection Transplantation 72 2001 935
10. K.M. Brown, E. Kondeatis, and R.W. Vaughan Influence of donor C3 allotype on late renal-transplantation outcome N Engl J Med 354 2006 2014
11. X. Wang, M. Rickert, and K.C. Garcia Structure of the quaternary complex of interleukin-2 with its alpha, beta, and gamma receptors Science 310 2005 1159
12. B.H. Nelson, J.D. Lord, and P.D. Greenberg Cytoplasmic domains of the interleukin-2 receptor beta and gamma chains mediate the signal for T-cell proliferation Nature 369 1994 333
13. L. Wei, A. Laurence, and J.J. O'Shea New insights into the roles of Stat5a/b and Stat3 in T cell development and differentiation Semin Cell Dev Biol 19 2008 394
14. A.L. Bayer, A. Yu, and D. Adeegbe Essential role for interleukin-2 for CD4(+)CD25(+) T regulatory cell development during the neonatal period J Exp Med 201 2005 769
15. R. Setoguchi, S. Hori, and T. Takahashi Homeostatic maintenance of natural Foxp3(+) CD25(+) CD4(+) regulatory T cells by interleukin (IL)2 and induction of autoimmune disease by IL-2 neutralization J Exp Med 201 2005 723
16. A. Antov, L. Yang, and M. Vig Essential role for STAT5 signaling in CD25+CD4+ regulatory T cell homeostasis and the maintenance of self-tolerance J Immunol 171 2003 3435
17. L. Graca, S.P. Cobbold, and H. Waldmann Identification of regulatory T cells in tolerated allografts J Exp Med 195 2002 1641
18. H. Suzuki, T.M. Kundig, and C. Furlonger Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor beta Science 268 1995 1472
19. H. Suzuki, G.S. Duncan, and H. Takimoto Abnormal development of intestinal intraepithelial lymphocytes and peripheral natural killer cells in mice lacking the IL-2 receptor beta chain J Exp Med 185 1997 499
20. T.R. Malek, A. Yu, and V. Vincek CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rbetadeficient mice Implications for the nonredundant function of IL-2 Immunity 17 2002 167
21. S.B. Gabriel, S.F. Schaffner, and H. Nguyen The structure of haplotype blocks in the human genome Science 296 2002 2225
22. Y.Y. Hsieh, C.C. Chang, and F.J. Tsai Interleukin-2 receptor beta (IL-2R beta)627 (*)C homozygote but not IL-12R beta 1 codon 378 or IL-18 105 polymorphism is associated with higher susceptibility to endometriosis Fertil Steril 84 2005 510
23. F.A. Kurreeman, N.A. Daha, and M. Chang Association of IL2RA and IL2RB with rheumatoid arthritis: a replication study in a Dutch population Ann Rheum Dis 68 2009 1789
24. Z. Pal, P. Antal, and A. Millinghoffer A novel galectin-1 and interleukin 2 receptor beta haplotype is associated with autoimmune myasthenia gravis J Neuroimmunol 2010
25. F. Matesanz, M. Fedetz, and L. Leyva Effects of the multiple sclerosis associated -330 promoter polymorphism in IL2 allelic expression J Neuroimmunol 148 2004 212
26. H.C. Wu, C.H. Chang, and L. Wan IL-2 gene C/T polymorphism is associated with prostate cancer J Clin Lab Anal 20 2006 245
27. E.A. Festen, P. Goyette, and R. Scott Genetic variants in the region harbouring IL2/IL21 associated with ulcerative colitis Gut 58 2009 799
28. D.M. Queiroz, I.E. Saraiva, and G.A. Rocha IL2-330G polymorphic allele is associated with decreased risk of Helicobacter pylori infection in adulthood Microbes Infect 11 2009 980
29. A. Morgun, N. Shulzhenko, and G.F. Rampim Interleukin-2 gene polymorphism is associated with renal but not cardiac transplant outcome Transplant Proc 35 2003 1344
30. A. Pawlik, L. Domanski, and J. Rozanski IL-2 and TNF-alpha promoter polymorphisms in patients with acute kidney graft rejection Transplant Proc 37 2005 2041
31. S.C. Hoffmann, E.M. Stanley, and E. Darrin Cox Association of cytokine polymorphic inheritance and in vitro cytokine production in anti-CD3/CD28- stimulated peripheral blood lymphocytes Transplantation 72 2001 1444
32. N. Kutukculer, K. Clark, and K.M. Rigg The value of posttransplant monitoring of interleukin (IL)2, IL-3, IL-4, IL-6, IL-8, and soluble CD23 in the plasma of renal allograft recipients Transplantation 59 1995 333
33. M.L. MacMillan, G.A. Radloff, and W.R. Kiffmeyer High-producer interleukin-2 genotype increases risk for acute graft-versus-host disease after unrelated donor bone marrow transplantation Transplantation 76 2003 1758
34. S. Satoh, M. Saito, and K. Inoue Association of cytokine polymorphisms with subclinical progressive chronic allograft nephropathy in Japanese renal transplant recipients: preliminary study Int J Urol 14 2007 990